Patents by Inventor JÓZSEF KLESPITZ

JÓZSEF KLESPITZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and method for flexible citrate anticoagulation during extracorporeal blood treatment using feed-forward control
    Patent number: 10953146
    Abstract: A system for extracorporeal blood treatment is disclosed that includes a haemofiltration device, a pump for pumping blood through the haemofiltration device, citrate means upstream to add citrate, calcium means downstream to add calcium solution, and a control configured to activate or inactivate the citrate addition means and/or the calcium addition means, wherein the control activates the citrate addition means at the beginning of blood treatment and for a first time period filters the blood with activated citrate addition means and continues to operate the citrate addition means until the end of blood treatment activates the calcium addition means after the first time period has elapsed when the total extracorporeal blood volume in the system has been filtered and citrate treated, continues to operate the calcium addition means in an active state during blood treatment to stably maintain a user-determined calcium addition rate, and continues to operate the calcium addition means in an active state after th
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: March 23, 2021
    Assignee: B. Braun Avitum AG
    Inventor: József Klespitz
  • SYSTEM AND METHOD FOR FLEXIBLE CITRATE ANTICOAGULATION DURING EXTRACORPOREAL BLOOD TREATMENT USING FEED-FORWARD CONTROL
    Publication number: 20160121035
    Abstract: A system for extracorporeal blood treatment is disclosed that includes a haemofiltration device, a pump for pumping blood through the haemofiltration device, citrate means upstream to add citrate, calcium means downstream to add calcium solution, and a control configured to activate or inactivate the citrate addition means and/or the calcium addition means, wherein the control activates the citrate addition means at the beginning of blood treatment and for a first time period filters the blood with activated citrate addition means and continues to operate the citrate addition means until the end of blood treatment activates the calcium addition means after the first time period has elapsed when the total extracorporeal blood volume in the system has been filtered and citrate treated, continues to operate the calcium addition means in an active state during blood treatment to stably maintain a user-determined calcium addition rate, and continues to operate the calcium addition means in an active state after th
    Type: Application
    Filed: October 1, 2015
    Publication date: May 5, 2016
    Inventor: JÓZSEF KLESPITZ